Every March, Bleeding Disorders Awareness Month provides an opportunity to educate, advocate, and elevate the voices of individuals and families living with inherited bleeding disorders.
It’s a time to reflect on how far care has come, and to recognize the innovations, systems of care, and community efforts that continue to improve quality of life for people affected by these conditions.
At the Center for Inherited Blood Disorders, awareness is more than education. It’s action. Through comprehensive, patient-centered care and leading-edge treatment options, we work every day to ensure individuals with bleeding disorders have access to the support, innovation, and specialized care they deserve.
What are Bleeding Disorders?
Bleeding disorders are a group of genetic conditions that affect the body’s ability to form blood clots properly. This can result in prolonged bleeding after injury or surgery, frequent nosebleeds, excessive bruising, internal bleeding, and joint or muscle damage over time.
Picture this: you get a small cut, and it doesn’t stop bleeding when it should. You bump into a table, and the bruise spreads larger and darker than expected. You have a minor fall, but instead of healing normally, your joint becomes swollen and painful. You avoid everyday activities because you’re worried about injuries that others wouldn’t think twice about.
For people living with bleeding disorders, ordinary moments can carry extraordinary risks, not because the injury is severe, but because the body lacks the ability to clot and heal effectively.
Some of the most well-known bleeding disorders include:
- Hemophilia A and Hemophilia B
- Von Willebrand disease
- Rare factor deficiencies
- Platelet disorders
While every condition presents differently, individuals living with bleeding disorders often require lifelong medical care, specialized treatment, and coordinated support to manage both physical and emotional health.
A Brief History of Progress
The history of bleeding disorder care is a story of resilience, advocacy, and innovation. Decades ago, treatment options were limited, and life expectancy and quality of life were significantly reduced. Over time, advancements in plasma-derived therapies, recombinant factor products, prophylactic treatment regimens, and home infusion transformed outcomes and independence for patients.
Advocacy efforts by patients, families, clinicians, and community organizations have also played a critical role in:
- Improving access to care
- Expanding research
- Increasing public awareness
- Strengthening patient protections
Today, individuals with bleeding disorders are living longer, healthier lives than ever before thanks to science, policy, and community-driven progress.
By the Numbers: The Impact of Bleeding Disorders
Bleeding disorders affect millions of people worldwide, yet they often remain misunderstood and underdiagnosed. A few powerful facts help illustrate their scope and impact:
- 1 in 10,000 people worldwide are born with Hemophilia A or B.
- Von Willebrand disease is the most common inherited bleeding disorder, affecting up to 1% of the global population.
- People with untreated bleeding disorders face a significantly higher risk of joint damage, chronic pain, and disability.
- Comprehensive care models are associated with better health outcomes, fewer hospitalizations, and lower long-term healthcare costs.
- Advances in treatment now allow many individuals with bleeding disorders to live full, independent, and active lives.
These numbers reflect not only prevalence, but the importance of early diagnosis, access to specialized care, and continued investment in research and innovation.
Treatment Advancements: From Factor Therapy to Gene Therapy
Modern bleeding disorder care has evolved far beyond traditional treatment models. Innovations now focus not only on managing symptoms, but on improving long-term outcomes, independence, and quality of life.
Gene Therapy: A New Era of Care
Gene therapy represents one of the most significant breakthroughs in hemophilia treatment in history. Gene therapies work by introducing functional copies of genes that enable the body to produce clotting factors on its own, reducing or eliminating the need for routine prophylactic infusions.
At CIBD, our Infusion Center provides advanced, patient-centered infusion services, including cutting-edge gene therapy treatments. As of January 2026, we have successfully completed six gene therapy infusions, offering two FDA-approved gene therapies for Hemophilia A and Hemophilia B.
These innovative treatments have allowed patients to experience meaningful improvements in daily life and independence.
Did You Know?
CIBD made history by delivering the first FDA-approved gene therapy infusion for Hemophilia A in the United States outside of a clinical trial setting.
In December 2023, our team successfully administered this groundbreaking treatment at CIBD, marking a major milestone in hemophilia care and expanding real-world access to life-changing gene therapy for patients.
This achievement reflects not only scientific progress, but our commitment to bringing innovation directly into patient care.
Comprehensive, Patient-Centered Care
While treatment advancements are critical, true progress in bleeding disorder care comes from comprehensive care models that address the whole person, not just the diagnosis.
At CIBD, care goes beyond infusion therapy. Our multidisciplinary approach supports patients through coordinated services that include:
- Hematology care
- Nursing and infusion services
- Care coordination
- Pharmacy support
- Education and advocacy
- Community connection
This model ensures that individuals and families receive care that is integrated, accessible, and responsive to their real-world needs.
To learn more about this approach, explore our blog on the comprehensive care model, which highlights how multidisciplinary care improves outcomes, access, and long-term health for people living with bleeding disorders.
Why Awareness Still Matters
Even with medical advancements, challenges remain:
- Access to specialized care
- Health equity gaps
- Insurance and reimbursement barriers
- Mental health impacts
- Caregiver burden
- Public understanding
Bleeding Disorders Awareness Month is not just about recognition. It’s about education, advocacy, and continued progress. It’s about ensuring that innovation reaches patients, care remains equitable, and systems continue to evolve to meet community needs.
Moving Forward Together
At CIBD, we believe that awareness must lead to action. Through innovation, comprehensive care, advocacy, and community partnership, we are committed to building a future where every person living with a bleeding disorder has access to high-quality, specialized, compassionate care.
This March, we honor the strength and resilience of the bleeding disorders community, celebrate how far care has come, and recommit to advancing access, innovation, and equity together.